HKSE - Delayed Quote HKD

WuXi XDC Cayman Inc. (2268.HK)

66.650 -1.250 (-1.84%)

At close: October 30 at 4:08:06 PM GMT+8

WuXi XDC Cayman (SEHK:2268) Stock May Be 32% Undervalued Despite ADC Awards

Simply Wall St. 6d ago

2268.HK
-1.84%
WuXi XDC Named the Winner of "Best CDMO" for the Fourth Consecutive Year and the Winner of "Best CRO" for the Second Consecutive Year

PR Newswire 16d ago

2268.HK
-1.84%
WuXi XDC Cayman (SEHK:2268) Secures GMP Release At New Singapore Site

Simply Wall St. 1mo ago

2268.HK
-1.84%
WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion

PR Newswire 1mo ago

2268.HK
-1.84%
Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

Pharmaceutical Technology 1mo ago

2268.HK
-1.84%
WuXi XDC Cayman Inc (STU:L74) (H1 2026) Earnings Call Highlights: Record Backlog and First $1B ...

GuruFocus.com 2mo ago

2268.HK
-1.84%
L74.SG
WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

PR Newswire 2mo ago

2268.HK
-1.84%
Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day

PR Newswire 4mo ago

2268.HK
-1.84%
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

GlobeNewswire 6mo ago

2268.HK
-1.84%
AKTX
WuXi XDC Cayman Inc (FRA:L74) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...

GuruFocus.com 7mo ago

2268.HK
-1.84%
DX-Y.NYB
Asian Equity Gems Estimated Below Fair Value In January 2026

Simply Wall St. 8mo ago

CVT.NZ

2268.HK
-1.84%
300253.SZ
Antibody-Drug Conjugates (ADC) CDMO Market Report: Evaluating End-to-End Bioconjugation, HPAPI Synthesis, and Strategies of Lonza, WuXi XDC, Samsung Biologics, and Catalent

GlobeNewswire 18d ago

207940.KS

2268.HK
-1.84%

U.S. markets closed

WuXi XDC Cayman Inc. (2268.HK)

WuXi XDC Cayman (SEHK:2268) Stock May Be 32% Undervalued Despite ADC Awards

WuXi XDC Named the Winner of "Best CDMO" for the Fourth Consecutive Year and the Winner of "Best CRO" for the Second Consecutive Year

WuXi XDC Cayman (SEHK:2268) Secures GMP Release At New Singapore Site

WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion

Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

WuXi XDC Cayman Inc (STU:L74) (H1 2026) Earnings Call Highlights: Record Backlog and First $1B ...

WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

WuXi XDC Cayman Inc (FRA:L74) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...

Asian Equity Gems Estimated Below Fair Value In January 2026

Antibody-Drug Conjugates (ADC) CDMO Market Report: Evaluating End-to-End Bioconjugation, HPAPI Synthesis, and Strategies of Lonza, WuXi XDC, Samsung Biologics, and Catalent